ストックスクリーナーアプリを入手
371.23
1.70%
-6.415
前日終値:
$377.64
開ける：
$373.51
24時間の取引高:
637.79K
Relative Volume:
0.23
時価総額：
$200.09B
収益：
$36.74B
当期純損益:
$7.71B
株価収益率:
26.08
EPS:
14.2333
ネットキャッシュフロー:
$8.10B
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
+1.37%
6か月 パフォーマンス:
+34.31%
1年 パフォーマンス:
+18.79%
1日の値動き範囲:
$368.50
$375.00
1週間の範囲:
$361.70
$380.14
52週間の値動き範囲:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
371.18 | 203.57B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
976.99 | 892.85B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.71 | 585.58B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
226.08 | 402.58B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
191.48 | 299.79B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.52 | 297.29B | 54.72B | 14.02B | 15.32B | 7.1855 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | 開始されました | Jefferies | Hold |
| 2026-02-20 | 開始されました | Barclays | Equal Weight |
| 2026-01-20 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-12-05 | アップグレード | Erste Group | Hold → Buy |
| 2025-11-24 | 再開されました | Truist | Hold |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-09-03 | 再開されました | Raymond James | Mkt Perform |
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
SevenBridge Financial Group LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN - MarketBeat
Inceptionr LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Starbucks, Amgen, CVS and Other Stocks Help This Income Fund Shine - Barron's
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference - Yahoo Finance
Kepler Cheuvreux Suisse SA Makes New $5 Million Investment in Amgen Inc. $AMGN - MarketBeat
Anti Oral Mucositis Drug Market Is Booming So Rapidly | Amgen • Merck & Co. Inc. • Bristol-Myers Squibb - openPR.com
Amgen Inc. $AMGN Stock Holdings Decreased by Richard Bernstein Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Russell Investments Group Ltd. - MarketBeat
Bank of Montreal Can Raises Stake in Amgen Inc. $AMGN - MarketBeat
Amgen further shrinking Montgomery County footprint, cutting 22 positions - The Business Journals
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.
Forecasting The Future: 15 Analyst Projections For Amgen - Benzinga
Van ECK Associates Corp Purchases 567,400 Shares of Amgen Inc. $AMGN - MarketBeat
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More - 24/7 Wall St.
Amgen Inc. $AMGN Stock Holdings Lifted by Capital Research Global Investors - MarketBeat
Capital International Ltd. CA Has $15.75 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital World Investors Acquires 1,935,876 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Sarl Purchases 46,052 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Investors Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Capital International Inc. CA Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Legal & General Group Plc - MarketBeat
Capital Group Investment Management PTE. LTD. Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital Group Private Client Services Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Schroder Investment Management Group - MarketBeat
Amgen Inc.: Close to a key resistance level - marketscreener.com
Crysvita Market Is Going to Boom | Kyowa Kirin • Amgen • Sanofi • Takeda Pharmaceutical - openPR.com
Rep. David Taylor Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
SNL mocks Amgen’s Otezla in bizarre sketch featuring Ryan Gosling - Medical Marketing and Media
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen
9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus - Yahoo Finance
Swiss National Bank Sells 77,600 Shares of Amgen Inc. $AMGN - MarketBeat
The first KRAS drugs have been sluggish on the market. Will the next generation fare better? - Pharma Voice
Therapeutics Companies Exceed Q4 2025 Revenue Estimates, Led by Novavax and AmgenNews and Statistics - IndexBox
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks - Finviz
First Trust Advisors LP Sells 46,048 Shares of Amgen Inc. $AMGN - MarketBeat
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Globe and Mail
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Motley Fool
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate - Yahoo Finance
Vinva Investment Management Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Korea Investment CORP Sells 22,072 Shares of Amgen Inc. $AMGN - MarketBeat
Blair William & Co. IL Reduces Position in Amgen Inc. $AMGN - MarketBeat
B. Metzler seel. Sohn & Co. AG Has $14.48 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation After Rocatinlimab Trial Halt And Pipeline Setback - simplywall.st
56,522 Shares in Amgen Inc. $AMGN Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
Neuberger Berman Group LLC Sells 3,315 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
3,603 Shares in Amgen Inc. $AMGN Purchased by Integrity Advisory Solutions LLC - MarketBeat
Pitcairn Co. Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
Amgen Inc (AMGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
0.18%
1.78%
大文字化:
|
ボリューム (24 時間):